Krowicki Z K, Hornby P J
Department of Pharmacology and Experimental Therapeutics, Louisiana State University Medical Center, New Orleans 70112.
Am J Physiol. 1993 Nov;265(5 Pt 1):G819-30. doi: 10.1152/ajpgi.1993.265.5.G819.
Little is known about the functional role of putative neurotransmitters in the nucleus raphe obscurus (NRO) in the control of gastric motor function, although thyrotropin-releasing hormone (TRH) and substance P (SP) have been detected in the cell bodies and/or fibers of this nucleus. Therefore, we investigated the effects of microinjection of these peptides (in a volume of 60 nl) into the caudal NRO of alpha-chloralose-anesthetized rats while recording intragastric pressure, pyloric and greater curvature motility, and blood pressure. L-Glutamate (30 nmol) was first microinjected into the NRO to identify the "gastric" region of the NRO and elicited significant increases in intragastric pressure as well as pyloric and greater curvature motility in all 16 animals. TRH (2-45 pmol, n = 16) microinjected into the same sites increased intragastric pressure as well as pyloric and greater curvature motility, and these effects were abolished by bilateral cervical vagotomy and atropine (0.5-1.0 mg/kg iv) but not by spinal cord transection. Microinjection of SP (45-405 pmol, n = 15) into the same sites decreased intragastric pressure; however, the inhibitory effect of SP on pyloric and greater curvature motility did not attain statistical significance. The effect of SP on intragastric pressure was completely abolished by bilateral vagotomy but not by systemic administration of atropine (1 mg/kg) or spinal cord transection. Microinjections of 45 pmol TRH and 405 pmol SP just outside of the NRO did not result in changes in gastric function. No overall significant changes in blood pressure were noted after microinjection of L-glutamate, TRH, or SP into the gastric region of the NRO. We conclude that both TRH and SP affect gastric motor function in the caudal NRO via a vagally mediated pathway; TRH apparently activates vagal cholinergic pathways, but the mechanism of SP-evoked gastric motor inhibition remains to be further investigated.
尽管在中缝隐核(NRO)的细胞体和/或纤维中已检测到促甲状腺激素释放激素(TRH)和P物质(SP),但关于NRO中假定神经递质在胃运动功能控制中的功能作用却知之甚少。因此,我们在记录胃内压、幽门和大弯蠕动以及血压的同时,研究了将这些肽(体积为60 nl)微量注射到α-氯醛糖麻醉大鼠的尾侧NRO中的作用。首先将L-谷氨酸(30 nmol)微量注射到NRO中以确定NRO的“胃”区域,在所有16只动物中均引起胃内压以及幽门和大弯蠕动显著增加。将TRH(2 - 45 pmol,n = 16)微量注射到相同部位可增加胃内压以及幽门和大弯蠕动,双侧颈迷走神经切断术和阿托品(0.5 - 1.0 mg/kg静脉注射)可消除这些作用,但脊髓横断术则不能。将SP(45 - 405 pmol,n = 15)微量注射到相同部位可降低胃内压;然而,SP对幽门和大弯蠕动的抑制作用未达到统计学显著性。SP对胃内压的作用可通过双侧迷走神经切断术完全消除,但全身给予阿托品(1 mg/kg)或脊髓横断术则不能。在NRO之外微量注射45 pmol TRH和405 pmol SP不会导致胃功能改变。将L-谷氨酸、TRH或SP微量注射到NRO的胃区域后,未观察到血压有总体显著变化。我们得出结论,TRH和SP均通过迷走神经介导的途径影响尾侧NRO中的胃运动功能;TRH显然激活迷走胆碱能途径,但SP诱发胃运动抑制的机制仍有待进一步研究。